TB 400
Alternative Names: TB-400Latest Information Update: 18 Sep 2022
At a glance
- Originator TrueBinding
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 06 Sep 2022 Early research in Unspecified in USA (Parenteral) (TrueBinding pipeline, September 2022)